Fourteenth Edition   ©2019

Julien's Primer of Drug Action

Claire D. Advokat (Louisiana State University) , Joseph E. Comaty (Louisiana State Office of Mental Health) , Robert M. Julien, Ph.D. (St. Vincent Hospital and Medical Center)

  • ISBN-10: 1-319-01585-9; ISBN-13: 978-1-319-01585-5; Format: Paper Text, 752 pages

The most current and comprehensive guide to psychopharmacology available.

Julien’s Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations. 

The thoroughly updated 14th edition features:

  • New coverage of opioids of abuse, and  drugs used to treat of opioid dependence and opioid overdose.
  • New research on the use of marijuana to treat Alzheimers, PTSD,  and Epilepsy.  
  • New coverage of pharmacological, physiological, and psychoactive effects  of synthetic marijuana including its toxicity.
  • New research on Cannabidiol (CBD) and its therapeutic uses
  • New research of the efficacy of  antipsychotics to treat  dementia, Parkinson’s, bipolar, OCD, PTSD,
  • New research on hallucinogenics for the treatment of various disorders including MDMA for the treatment of PTSD, Psilocybin for treatment of depression and end-of-life anxiety, and Ayahuasca to treat psychiatric disorders
  • The use of genetic testing to predict effectiveness of  antidepressant treatment
  • New research on the use of ketamine for the treatment of depression